Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Gilead, Anadys Enter Deal For HTP With Viral Target

June 11, 2002

FeRx Raises $15M To Pay For Phase II/III Trial Of MTC-DOX

June 7, 2002

FeRx Raises $15M To Pay For Phase II/III Trial Of MTC-DOX

June 7, 2002

TransForm, ALZA Sign Deal For Transdermal Products

June 6, 2002

TransForm, ALZA Sign Deal For Transdermal Products

June 6, 2002

ActivX Using Proteomics Platform In Diabetes Alliance With Kyorin

June 5, 2002

Libraria Names New CEO To Help Move Company Forward

June 5, 2002

ActivX Using Proteomics Platform In Diabetes Alliance With Kyorin

June 5, 2002

Libraria Names New CEO To Help Move Company Forward

June 5, 2002

Genta, Aventis Adding Patients To Trial; Move Pushes Back NDA

June 4, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.